ICAM1 and cancer: This posttranslational modification allows type-1 matrix metalloproteinases (MT1-MMP) to interact with ICAM-1 in endothelial cells and to cleave the ICAM-1 ectodomain, resulting in soluble (s)ICAM-1, a process that seems important for leukocyte TEM and cancer metastasis [69].